Latest news

As a company founded on science and innovation, SOLVO is committed to providing partners and customers with the latest information on our research and product development.

SOLVO Biotechnology Introduces a Novel MDCKII-MDR1 Monolayer Product in Collaboration with ADVANCELL:

PreadyPort™ MDR1

the Ready-to-use Transfected MDCKII-MDR1 Monolayer

Dr. István Sziráki, Head of Microdialysis Department has been invited to participate on DMDG Open Meeting in Cambridge, UK. Mr Sziráki's presentation "Microdialysis and in vitro techniques to study efflux transporter - transporter modulator interactions and brain penetration of drugs – correlation studies" is be available now. Please click here to open presentation.

SOLVO Biotechnology introduces the MRP4 and the rat Mrp2 Vesicular Transport Assays and N-methyl-quinidine (NMQ).
• MRP4
• rat Mrp2 VT
• N-methyl-quinidine (NMQ)

We are pleased to inform you that SOLVO Biotechnology introduces the specific P-gp inhibitor PSC 833 (valspodar, Amray) and three new PrediScreen services

* PSC 833 (valspodar, Amray)
* mouse Bcrp1 vesicular transport assay
* OAT3 uptake transporter assay
* OCT2 uptake transporter assay using metformin as substrate.

For more information please click here.

SOLVO Biotechnology has appointed Berend Oosterhuis as Business Development Director.

SOLVO is the exclusive commercial provider of B-CLEAR^® kits and a provider of B-CLEAR^® services in Europe.

SOLVO Biotechnology organized it’s first SOLVO Transporter Symposium and Training between May 22-23 in Budapest.

I am pleased to inform you, that SOLVO is introducing the new P-gp PREDIVEZ kit that is a breakthrough in P-gp interaction assessment. The assay measures drug-transporter interaction in membrane vesicles expressing human P-gp or rat Mdr1b.
The revolutionary PREDIVEZ kit allows a faster and more cost effective investigation of the drug candidate and P-gp interaction than lower throughput cellular assays, such as Caco-2, MDCK-MDR1 or LLC-PK MDR1 cell-based systems.

RALEIGH, NC. U.S.A. and Budapest, Hungary
SOLVO Biotechnology, a leading provider of drug transport technologies, cell products and contract in vitro and in vivo laboratory services, and Qualyst, Inc., a leader in the development and commercialization of novel and proprietary absorption, distribution, metabolism, excretion and toxicity (ADMET) technologies, today announced that SOLVO has obtained a license to Qualyst's B-CLEAR^® system. B-CLEAR^® products and services are projected to be available in Europe from SOLVO in early 2008. Financial details were not disclosed.

The Deloitte Technology Fast 50 Central European annual award honours the fastest growing Central European technology companies, based on percentage revenue growth over a five-year period.

SOLVO Biotechnology (Hungary) and KRISHGEN BioSystems (India) announce Distribution and Service Representation Agreement for SOLVO's Membrane Transporter Assay Products and Services in India, Singapore, Malaysia, Hong Kong, Thailand, Srilanka, Bangladesh, Pakistan and Nepal.

Budapest, Hungary - Le Perray-en-Yvelines, France; 4th September, 2007 - SOLVO Biotechnology and tebu-bio announced that they have formed a partnership to distribute and represent SOLVO's leading Membrane Transporter Assay Products and Services in the Europe.

SOLVO Biotechnology announced today that the company has received the UKAS accredited ISO 9001:2000 quality management system certification for the development and production of methods and reagents, contract research services.

SOLVO Biotechnology is introducing the revolutionary PREDIVEZ Fluorescent Vesicular Transport Assay Kit for MRP2.

SOLVO Biotechnology announced today the appointment of Professor Yuichi Sugiyama to its Scientific Advisory Board. Professor Sugiyama is recognized as the global leader in the field of drug transporter science.

SOLVO Biotechnology is introducing the revolutionary BCRP HAM membranes and vesicles!

Management-buy-out at SOLVO

SOLVO Biotechnology and XenoTech LLC Announce North American (US and Canada) Distribution and Service Representation Agreement for SOLVO's Membrane Transporter Assay Products and Services from January 1st 2007.

SOLVO Biotechnology announced today the appointment of Karl Kuchler to its Strategic Advisory Board. Dr. Kuchler is widely recognized in the drug transporter community as leader and champion of collaboration between academia and industry!

SOLVO Biotechnology is launching the new Mouse Bsep and MRP5 Vesicular Transport assays!

SOLVO Biotechnology is launching the revolutionary PREDEASY ATPase Assay Kit.

SOLVO Biotechnology announced today the appointment of Bruno Stieger to its Strategic Advisory Board. Dr. Stieger is recognized as a global leader in the field of drug transporter science.

SOLVO Biotechnology announced today the appointment of Professor Dietrich Keppler to its International Scientific Advisory Board. Professor Keppler is recognized as a global leader in the field of drug transporter science.

SOLVO Biotechnology won this year's Innovation Grand Prize. The company's outstanding product reduces the time of drug development research and cuts associated costs.